COA with every orderTracked worldwide shippingDispatch Mon–SatFor research use only

Research Products

Showing 65–65 of 65 results

  • Retatrutide 60mg

    Retatrutide 60mg

    60mgHPLC99.543%
    $253

    Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.

    View COA (Certificate of Analysis)

WhatsApp us